FI55656C - Foerfarande foer framstaellning av terapeutiskt anvaendbara n-benshydryl-n'-p-hydroxibensyl-piperazin - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara n-benshydryl-n'-p-hydroxibensyl-piperazin

Info

Publication number
FI55656C
FI55656C FI1797/73A FI179773A FI55656C FI 55656 C FI55656 C FI 55656C FI 1797/73 A FI1797/73 A FI 1797/73A FI 179773 A FI179773 A FI 179773A FI 55656 C FI55656 C FI 55656C
Authority
FI
Finland
Prior art keywords
therapeutic
hydroxibensyl
benshydryl
piperazine
framework
Prior art date
Application number
FI1797/73A
Other languages
English (en)
Finnish (fi)
Other versions
FI55656B (fi
Inventor
Thomas Raabe
Josef Scholtholt
Eckhard Schraven
Rolf-Eberhard Nitz
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2226767A external-priority patent/DE2226767A1/de
Priority claimed from DE19732312212 external-priority patent/DE2312212A1/de
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of FI55656B publication Critical patent/FI55656B/fi
Application granted granted Critical
Publication of FI55656C publication Critical patent/FI55656C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
FI1797/73A 1972-06-02 1973-06-01 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-benshydryl-n'-p-hydroxibensyl-piperazin FI55656C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2226767A DE2226767A1 (de) 1972-06-02 1972-06-02 N-benzhydryl-n'-p-hydroxybenzylpiperazin und verfahren zu seiner herstellung
DE19732312212 DE2312212A1 (de) 1973-03-12 1973-03-12 N-(p-chlorbenzhydryl)-n'-p-hydroxybenzyl-piperazin und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
FI55656B FI55656B (fi) 1979-05-31
FI55656C true FI55656C (fi) 1979-09-10

Family

ID=25763357

Family Applications (1)

Application Number Title Priority Date Filing Date
FI1797/73A FI55656C (fi) 1972-06-02 1973-06-01 Foerfarande foer framstaellning av terapeutiskt anvaendbara n-benshydryl-n'-p-hydroxibensyl-piperazin

Country Status (26)

Country Link
US (1) US3868377A (sv)
JP (1) JPS4948687A (sv)
AR (5) AR194688A1 (sv)
AT (3) AT331802B (sv)
AU (1) AU470393B2 (sv)
BG (3) BG20371A3 (sv)
CA (1) CA980347A (sv)
CH (4) CH593959A5 (sv)
CS (4) CS178430B2 (sv)
DD (1) DD106644A5 (sv)
DK (1) DK139751C (sv)
EG (1) EG11434A (sv)
ES (3) ES415464A1 (sv)
FI (1) FI55656C (sv)
FR (1) FR2186265B1 (sv)
GB (1) GB1386916A (sv)
HU (1) HU165312B (sv)
IE (1) IE37717B1 (sv)
IL (1) IL42384A (sv)
NL (1) NL7306771A (sv)
NO (1) NO138026C (sv)
PH (1) PH9485A (sv)
PL (3) PL91050B1 (sv)
RO (3) RO68379A (sv)
SE (1) SE396385B (sv)
SU (4) SU508196A3 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59101475A (ja) * 1982-12-02 1984-06-12 Nippon Chemiphar Co Ltd 新規ピペラジン誘導体およびその製造法ならびにこれを含有する脳循環改善剤
HU186656B (en) * 1982-12-28 1985-09-30 Richter Gedeon Vegyeszet Process for producing new benzhydryl-piperazine derivatives, acid additionak salts and pharmaceutical compositions containing them
GB8320701D0 (en) * 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent
JPS60222472A (ja) * 1984-03-30 1985-11-07 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
US4978666A (en) * 1988-08-05 1990-12-18 Nippon Chemiphar Co., Ltd. Optically active piperazine derivative
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
ES2156934T3 (es) * 1993-12-08 2001-08-01 Alcon Lab Inc Compuestos que presentan una potente actividad de antagonistas del calcio y de antioxidantes y su utilizacion como agentes citoprotectores.
CA2724887A1 (en) * 2008-06-02 2009-12-10 Cipla Limited Processes for the synthesis of levocetirizine and intermediates for use therein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2709169A (en) * 1955-05-24 X c chs
US3051710A (en) * 1959-12-21 1962-08-28 Lakeside Lab Inc Glycolic acid amide derivatives of piperazine and use thereof

Also Published As

Publication number Publication date
AT331801B (de) 1976-08-25
AR200764A1 (es) 1974-12-13
FR2186265A1 (sv) 1974-01-11
SE396385B (sv) 1977-09-19
IL42384A0 (en) 1973-07-30
IL42384A (en) 1976-12-31
CS178429B2 (sv) 1977-09-15
ATA483273A (de) 1975-11-15
FR2186265B1 (sv) 1976-03-05
RO62900A (ro) 1982-10-26
ES415465A1 (es) 1976-05-16
GB1386916A (en) 1975-03-12
AR201001A1 (es) 1975-02-06
SU507238A3 (ru) 1976-03-15
AT331252B (de) 1976-08-10
AU5634373A (en) 1974-12-05
CS182234B2 (en) 1978-04-28
PL94759B1 (pl) 1977-08-31
BG20595A3 (bg) 1975-12-05
FI55656B (fi) 1979-05-31
CH579064A5 (sv) 1976-08-31
RO68379A (ro) 1981-11-24
CA980347A (en) 1975-12-23
BG20596A3 (bg) 1975-12-05
ATA483073A (de) 1975-12-15
ES415464A1 (es) 1976-05-01
CS178430B2 (sv) 1977-09-15
AR196936A1 (es) 1974-02-28
AR204987A1 (es) 1976-03-31
DD106644A5 (sv) 1974-06-20
PL91050B1 (sv) 1977-02-28
HU165312B (sv) 1974-08-28
IE37717L (en) 1973-12-02
DK139751B (da) 1979-04-09
SU508196A3 (ru) 1976-03-25
SU577995A3 (ru) 1977-10-25
NO138026B (no) 1978-03-06
US3868377A (en) 1975-02-25
AU470393B2 (en) 1976-03-11
CH594651A5 (sv) 1978-01-13
CS182248B2 (en) 1978-04-28
NL7306771A (sv) 1973-12-04
PL97129B1 (pl) 1978-02-28
NO138026C (no) 1978-06-14
IE37717B1 (en) 1977-09-28
ES415466A1 (es) 1976-05-16
PH9485A (en) 1976-01-08
DK139751C (da) 1979-09-17
AT331802B (de) 1976-08-25
CH593959A5 (sv) 1977-12-30
CH574949A5 (sv) 1976-04-30
ATA483173A (de) 1975-12-15
AR194688A1 (es) 1973-07-31
EG11434A (en) 1977-09-30
SU530644A3 (ru) 1976-09-30
RO68378A (ro) 1982-02-01
BG20371A3 (bg) 1975-11-05
JPS4948687A (sv) 1974-05-11

Similar Documents

Publication Publication Date Title
NO783636L (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
FI54301B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
FI55656B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-benshydryl-n'-p-hydroxibensyl-piperazin
FI55998B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-alkylamino-dihydropyridiner
FI55988C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara o-acylfenoletanolaminer
SE398750B (sv) Forfarande for framstellning av metylamino-2-metyl-4'-piperazinyl-4-klor-6-metyltio-5-pyrimidin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE385906B (sv) Forfarande for framstellning av kardenolid-3-(2'-desoxi-glykosider)
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
BE755833A (fr) Badernes rotatives d'etrave
SE382971B (sv) Forfarande for framstellning av ?72238pu?7216o?712
SE396377B (sv) Forfarande for framstellning av difenylmetoxietylaminer
SE386673B (sv) Forfarande for framstellning av 2-amino-2-oxazoliner
SE408643B (sv) Forfarande for framstellning av morfantridiner
FI56171B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva asylerade piperidin-, tetrahydropyridin- och pyridinderivat